1 / 4

Table S1: Characteristics of the cancer patients

Chen et al , Supplementary Material. Table S1: Characteristics of the cancer patients. Chen et al , Supplementary Material. Table S2: Serum concentrations of galectins and cytokines in human breast and colon cancer patients. Chen et al , Supplementary Material. A. B. C. D.

mattox
Télécharger la présentation

Table S1: Characteristics of the cancer patients

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Chen et al, Supplementary Material Table S1: Characteristics of the cancer patients

  2. Chen et al, Supplementary Material Table S2: Serum concentrations of galectins and cytokines in human breast and colon cancer patients

  3. Chen et al, Supplementary Material A B C D Fig S1. Recombinant human galectin-2, -4 an d-8 induce cytokine secretion from mouse vein endothelial cells. C57BL/6 mouse vein endothelial cells (MVECs) (from Cell Biologics, IL) were treated with 1.5μg/ml recombinant human galectin-2, -4, -8 or BSA for 24 hr at 370C before the G-CSF (A), IL-6 (B), GROα ( C) and MCP-1 (D) levels in the culture media were determined by individual mouse cytokine ELISA. The data are expressed as percentage compared with BSA-treated controls. *p<0.05, **p<0.01 (ANOVA, Bonferroni).

More Related